Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women.

Dow A, Kayira D, Hudgens MG, Van Rie A, King CC, Ellington S, Chome N, Kourtis A, Turner AN, Kacheche Z, Jamieson DJ, Chasela C, van der Horst C.

Infect Dis Obstet Gynecol. 2013;2013:340702. doi: 10.1155/2013/340702. Epub 2013 Dec 5.

2.

Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.

Walter J, Mwiya M, Scott N, Kasonde P, Sinkala M, Kankasa C, Kauchali S, Aldrovandi GM, Thea DM, Kuhn L.

J Infect Dis. 2006 Dec 1;194(11):1510-8. Epub 2006 Oct 19.

3.

Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.

Kapito-Tembo A, Meshnick SR, van Hensbroek MB, Phiri K, Fitzgerald M, Mwapasa V.

J Infect Dis. 2011 Feb 15;203(4):464-72. doi: 10.1093/infdis/jiq072. Epub 2011 Jan 7.

4.

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.

Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.

J Infect Dis. 2007 Dec 1;196(11):1585-94. Epub 2007 Oct 25.

PMID:
18008241
5.

Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.

Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP, Skarbinski J.

J Infect Dis. 2013 Sep;208(6):907-16. doi: 10.1093/infdis/jit276. Epub 2013 Jun 24.

6.

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.

González R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S, Aponte JJ, Bulo H, Kabanywanyi AM, Katana A, Maculuve S, Mayor A, Nhacolo A, Otieno K, Pahlavan G, Rupérez M, Sevene E, Slutsker L, Vala A, Williamsom J, Menéndez C.

PLoS Med. 2014 Sep 23;11(9):e1001735. doi: 10.1371/journal.pmed.1001735. eCollection 2014 Sep.

7.

Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.

Denoeud-Ndam L, Zannou DM, Fourcade C, Taron-Brocard C, Porcher R, Atadokpede F, Komongui DG, Dossou-Gbete L, Afangnihoun A, Ndam NT, Girard PM, Cot M.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):198-206. doi: 10.1097/QAI.0000000000000058.

PMID:
24220287
8.

Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants.

Dow A, Kayira D, Hudgens M, Van Rie A, King CC, Ellington S, Kourtis A, Turner AN, Meshnick S, Kacheche Z, Jamieson DJ, Chasela C, van der Horst C.

Pediatr Infect Dis J. 2012 Aug;31(8):842-7. doi: 10.1097/INF.0b013e31825c124a.

9.

Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.

Davis NL, Barnett EJ, Miller WC, Dow A, Chasela CS, Hudgens MG, Kayira D, Tegha G, Ellington SR, Kourtis AP, van der Horst C, Jamieson DJ, Juliano JJ.

Clin Infect Dis. 2015 Aug 1;61(3):368-74. doi: 10.1093/cid/civ309. Epub 2015 Apr 21.

10.

Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.

Mbeye NM, ter Kuile FO, Davies MA, Phiri KS, Egger M, Wandeler G; IeDEA-Southern Africa.

Trop Med Int Health. 2014 Sep;19(9):1057-67. doi: 10.1111/tmi.12352. Epub 2014 Jul 8. Review.

11.

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.

Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, Steketee RW, Hamel M.

J Infect Dis. 2006 Aug 1;194(3):286-93. Epub 2006 Jun 20.

PMID:
16826475
12.

Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.

Diakite OS, Kayentao K, Traoré BT, Djimde A, Traoré B, Diallo M, Ongoiba A, Doumtabé D, Doumbo S, Traoré MS, Dara A, Guindo O, Karim DM, Coulibaly S, Bougoudogo F, Ter Kuile FO, Danis M, Doumbo OK.

Clin Infect Dis. 2011 Aug 1;53(3):215-23. doi: 10.1093/cid/cir374. Erratum in: Clin Infect Dis. 2012 Feb 1;54(3):454. Maiga, Oumou M [corrected to Diakite, Oumou S Maïga]; Traoré, Mouctar [corrected to Diallo, Mouctar].

PMID:
21765069
13.

Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.

Ibitokou SA, Denoeud-Ndam L, Ezinmegnon S, Ladékpo R, Zannou DM, Massougbodji A, Girard PM, Cot M, Luty AJ, Ndam NT.

Am J Trop Med Hyg. 2015 Aug;93(2):287-92. doi: 10.4269/ajtmh.14-0653. Epub 2015 Jun 22.

14.

Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.

Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH.

J Infect Dis. 2007 Dec 1;196(11):1577-84. Epub 2007 Oct 25.

PMID:
18008240
15.

Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.

Capan-Melser M, Mombo Ngoma G, Akerey-Diop D, Basra A, Würbel H, Groger M, Mackanga JR, Zoleko-Manego R, Schipulle U, Schwing J, Lötsch F, Rehman K, Matsiegui PB, Agnandji ST, Adegnika AA, Bélard S, González R, Kremsner PG, Menendez C, Ramharter M.

J Antimicrob Chemother. 2015;70(6):1898-902. doi: 10.1093/jac/dkv041. Epub 2015 Feb 25.

PMID:
25722300
16.

Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.

Green M, Otieno K, Katana A, Slutsker L, Kariuki S, Ouma P, González R, Menendez C, ter Kuile F, Desai M.

Malar J. 2016 Jan 5;15:7. doi: 10.1186/s12936-015-1049-9.

17.

Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study.

van Eijk AM, Ayisi JG, ter Kuile FO, Otieno JA, Misore AO, Odondi JO, Rosen DH, Kager PA, Steketee RW, Nahlen BL.

Trop Med Int Health. 2004 Mar;9(3):351-60.

PMID:
14996364
18.

Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial.

Manyando C, Njunju EM, Mwakazanga D, Chongwe G, Mkandawire R, Champo D, Mulenga M, De Crop M, Claeys Y, Ravinetto RM, van Overmeir C, Alessandro UD, Van Geertruyden JP.

PLoS One. 2014 May 15;9(5):e96017. doi: 10.1371/journal.pone.0096017. eCollection 2014.

19.

Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.

Suthar AB, Vitoria MA, Nagata JM, Anglaret X, Mbori-Ngacha D, Sued O, Kaplan JE, Doherty MC.

Lancet HIV. 2015 Apr;2(4):e137-50. doi: 10.1016/S2352-3018(15)00005-3. Epub 2015 Mar 3. Review.

PMID:
26424674
20.

Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.

Hoffmann CJ, Fielding KL, Charalambous S, Innes C, Chaisson RE, Grant AD, Churchyard GJ.

AIDS. 2010 Jul 17;24(11):1709-16. doi: 10.1097/QAD.0b013e32833ac6bc.

Supplemental Content

Support Center